Various dietary supplements are known to cause metabolic changes and hormonal regulation and have a potential impact on increasing pregnancy rates
Weight loss typically continues, with clinical trials showing that semaglutide 2.4 mg (Wegovy) produces average weight loss of approximately 15% by week 68, while tirzepatide (Zepbound) has demonstrated weight loss of approximately 15-21% across different doses by week 72
This is not just medication
Both groups also received the same lifestyle counseling, so the comparison reflects semaglutide added to that counseling, not semaglutide alone
With a healthy nervous system, over-production of the stress hormone that causes the fight or flight response (cortisol) can be prevented
Importantly, future studies should evaluate potential drugnutrient interactions to reduce the risk of adverse cross-reactions